| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 10/01/2008 | EP1317274B1 Peptide composition for treatment of periodontal diseases and prevention of skin aging |
| 10/01/2008 | CN101277962A Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 10/01/2008 | CN101277713A Composition for acceleration of type I collagen production |
| 10/01/2008 | CN101277697A Dermatitis remedies |
| 10/01/2008 | CN101277690A Abnormal protein removing composition |
| 10/01/2008 | CN101275108A Formula of blood-nourishing skin-whitening health wine and preparation thereof |
| 10/01/2008 | CN101274118A Physiotherapy electrode plate clamping self-pasting medicine carrying membrane and manufacture method thereof |
| 10/01/2008 | CN101274093A Chinese medicine for curing fungal dermatopathy |
| 10/01/2008 | CN101274089A Brain tonic and hair care formulation for preventing alopecia, restoring hair and nourishing hair |
| 10/01/2008 | CN101274080A Compound formulation of tablets for eliminating acne, purging intense heat, defeating viral and bacterial infections |
| 10/01/2008 | CN101274074A Compound formulation of tablets for eliminating chloasma on face and producing process |
| 10/01/2008 | CN101274073A Compound formulation of tablets for nourishing yin and beautifying female and producing process thereof |
| 10/01/2008 | CN101274049A Medicament for curing multiple traumas |
| 10/01/2008 | CN101274048A Compound formulation of capsules for curing injuries from falls and preparing technique |
| 10/01/2008 | CN101274047A External-use ointment for treating burn and method of preparing the same |
| 10/01/2008 | CN101274045A Exterior-applied medicament for treating psoriasis |
| 10/01/2008 | CN101274038A Method for testing content in quality control of Bittersweet Herb gel preparation for eliminating rash and relieving itching |
| 10/01/2008 | CN101274037A Composition for curing skin pruritus and preparation method thereof and quality control method |
| 10/01/2008 | CN101274018A Compound formulation of capsules for curing alopecia and preparing process |
| 10/01/2008 | CN101273988A Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| 10/01/2008 | CN101273971A Ethosomes preparation of antimycotics pharmaceutical and method for preparing the same |
| 10/01/2008 | CN100422316C Neutralizing human anti-IGFR antibody |
| 10/01/2008 | CN100422315C Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 10/01/2008 | CN100422173C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 10/01/2008 | CN100422172C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 10/01/2008 | CN100422164C Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 10/01/2008 | CN100422160C Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives |
| 10/01/2008 | CN100421731C Injection liquid of human autogenous collagen living cell and preparation method thereof |
| 10/01/2008 | CN100421710C Medicament for treating tumor and ulcer and preparation method thereof |
| 10/01/2008 | CN100421701C Medicine for treating brun and scald and preparing method |
| 10/01/2008 | CN100421670C Amikacin paste and preparing method and use |
| 10/01/2008 | CN100421660C Composition for the treatment of vitiligo |
| 10/01/2008 | CN100421647C Topical anti-inflammatory compositions and methods of reducing inflammation |
| 09/30/2008 | US7429663 7-(Pyrimidin-4-yl)-Imidazo[1,2-a]Pyrimidin-5(1H)-ones as GSK3β inhibitors |
| 09/30/2008 | US7429592 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor |
| 09/30/2008 | US7429488 Method for processing lipoaspirate cells |
| 09/30/2008 | US7429377 Therapeutic composition containing a plurality of immobilized proteases |
| 09/30/2008 | US7429252 That brings ambient air into contact with a porous cathode mounted in a housing, reduces the oxygen to neutral species, diffuses it through an ion conducting membrane to a phosphoric acid treated porous anode, oxidizes the neutral species back to oxygen, and carries to the wound; venous ulcers |
| 09/30/2008 | CA2374763C Composition for improving skin lipid barrier function |
| 09/30/2008 | CA2355470C Benzoheterocycles and their use as mek inhibitors |
| 09/30/2008 | CA2338220C Substituted imidazoles having cytokine inhibitory activity |
| 09/25/2008 | WO2008116157A2 Mesenchymal stem cells and uses therefor |
| 09/25/2008 | WO2008115098A2 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and the use thereof |
| 09/25/2008 | WO2008114819A1 Novel adenine compound |
| 09/25/2008 | WO2008114817A1 Novel adenine compound |
| 09/25/2008 | WO2008114812A1 Jak inhibitor |
| 09/25/2008 | WO2008114732A1 Wrinkling-preventing and -modifying agent |
| 09/25/2008 | WO2008114660A1 Composition having antioxidant activity |
| 09/25/2008 | WO2008114536A1 Dehydroepiandrosterone production promoter and use thereof |
| 09/25/2008 | WO2008114488A1 Therapeutic agent for autoimmune skin disease containing polypeptide as active ingredient |
| 09/25/2008 | WO2008114487A1 Therapeutic agent for autoimmune skin disease containing polypeptide as active ingredient |
| 09/25/2008 | WO2008114125A1 Compositions containing compounds having steroid structure and their use for inducing the proliferation and differentiation of stem cells of the organism |
| 09/25/2008 | WO2008114082A1 Methods, processes and compositions comprising the protein calmodulin (cam) for treatment of damaged or ageing skin, and/or hair loss |
| 09/25/2008 | WO2008114022A1 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents |
| 09/25/2008 | WO2008113863A2 Nitrosated derivatives of 2,5-dihydroxybenzene compounds |
| 09/25/2008 | WO2008113450A2 Use of chroman-4-on-derivatives |
| 09/25/2008 | WO2008113400A1 Preparations for the topical treatment of skin diseases |
| 09/25/2008 | WO2008113146A1 Pharmaceutical composition with antifungal activity containing cymbopogon nardus, its process, and use |
| 09/25/2008 | WO2008050157A3 Ozonated oil formulations |
| 09/25/2008 | WO2008002449A3 Glycomimetic inhibitors of siglec-8 |
| 09/25/2008 | US20080234390 Skin pore minimizers and skin elasticity improvers |
| 09/25/2008 | US20080234346 Pyrazalidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 09/25/2008 | US20080234344 Amino Acid and Peptide Conjugates of Arylalkylic Acids for Cosmetic Use |
| 09/25/2008 | US20080234342 Applying a mixture of a retinoid, antimicotic compound that enhances conversion of retinoid to retinoic acid and prevents the retinoic acid degradation (bifonazole, climbazole), fatty alcohol and/or fatty acid, and cosmetic vehicle to treat the skin for wrinkles, psoriasis, age spots or discoloration. |
| 09/25/2008 | US20080234315 3-Endo)-3-[2,2-Bis-(3-hydroxy-phenyl)-ethenyl]-8,8-dimethyl-8-azonia-bicyclo[3.2.1]octane bromide; chronic obstructive lung disease, chronic bronchitis, asthma, chronic respiratory obstruction, pulmonary fibrosis, pulmonary emphysema, allergic rhinitis |
| 09/25/2008 | US20080234285 Renin inhibitor such as (S),4(S),5(S),7(S) N-(3-amino-2,2-dimethyl-3-oxopropyl)-2,7-di(1-methylethyl)-4-hydroxy-5-amino-8-[4-methoxy-3-(3-methoxy-propoxy)phenyl]-octanamide and PDGF receptor tyrosine kinase inhibitor such as Imatinib, thrombosis, psoriasis, fibrosis, dermatosclerosis, atherosclerosis |
| 09/25/2008 | US20080234258 Dihydroxyanthraquinones and Their Use |
| 09/25/2008 | US20080234241 Melanogenesis inhibitors and whitening agents comprising ergosterol derivative and compositions containing ergosterol derivative |
| 09/25/2008 | US20080234239 Polyaphron dispersion, vitamin D or vitamin D analogue and a corticosteroid; use in the treatment of psoriasis |
| 09/25/2008 | US20080234214 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration |
| 09/25/2008 | US20080234195 Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations |
| 09/25/2008 | US20080234194 Growth factor mediated cosmeceuticals and use thereof to enhance skin quality |
| 09/25/2008 | US20080234189 Treatment of inflammation related to an autoimmune disease, such as asthma, arthritis, psoriasis, or inflammatory bowel disease by adminstering an extracellular adherence protein; recruitment of leukocytes or neutrophils to an inflammation site is prevented |
| 09/25/2008 | US20080234176 Modified peptides and their uses |
| 09/25/2008 | US20080233185 Using dimethyl fumarate and/or diethyl fumarate, calcium alkyl fumarate, calcium methyl fumarate and/or calcium ethyl fumarate, zinc methyl fumarate and/or zinc ethyl fumarate, methyl hydrogen fumarate and/or ethyl hydrogen fumarate; sclerodermia, osteochondritis syphilitica (Wegener's disease) |
| 09/25/2008 | US20080233145 Pharmaceutical Compositions Comprising Old Man's Beard (Usnea Barbata) and St. John's Wort (Hypericum Perforatum) and Their Use |
| 09/25/2008 | US20080233113 Cardiovascular conditions, ischemia-reperfusion injury, atherosclerosis, inflammatory gastrointestinal disorder, pulmonary condition, musculoskeletal conditions, renal conditions, skin conditions, organ or tissue transplants, nervous system disorders |
| 09/25/2008 | US20080233091 use of a live culture of a non-pathogenic food-grade probiotic bacterium ( lactococcus or lactobacillus strains of lactic acid bacteria) in the treatment of infectious diseases, may be a localised infection of the skin, including an infected wound, a urinary tract infection or mastitis |
| 09/25/2008 | US20080233078 Therapeutic polyesters and polyamides |
| 09/25/2008 | US20080233074 Composition and Method For Dry Cow Udder Protection |
| 09/25/2008 | DE102007013857A1 Neue Zusammensetzungen, insbesondere für die topische Behandlung von Hauterkrankungen New compositions, particularly for topical treatment of skin diseases |
| 09/25/2008 | CA2681320A1 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents |
| 09/25/2008 | CA2681084A1 Pharmaceutical compositions with antifungal activity containing cymbopogon nardus extract, process of obtaining the extracts, and their use |
| 09/25/2008 | CA2680397A1 Novel adenine compound |
| 09/24/2008 | EP1971369A2 Combination of anticholinergics, glucocorticoids, beta2-agonists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases |
| 09/24/2008 | EP1971353A2 Cosmetic compositions based on essential oils and use thereof in pain relief |
| 09/24/2008 | EP1971331A2 4-oxo-(iso)tretinoin for the topical treatment of severe dermatological disorders |
| 09/24/2008 | EP1513520B1 Substituted pyrrolines as kinase inhibitors |
| 09/24/2008 | EP1509528B1 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/24/2008 | EP1411128B1 Recombinant viral vectors containing the human urokinase plasminogen activator gene and their utilization in the treatment of hepatic fibrosis |
| 09/24/2008 | EP1404291B1 Water-free ubiquinone concentrate |
| 09/24/2008 | EP1365762B1 Method for increasing leptin levels using nicotinic acid compounds |
| 09/24/2008 | EP1341535B1 Skin whiteners containing hydroxytetronic acid |
| 09/24/2008 | CN101273064A Anti-TrkB monoclonal antibodies and uses thereof |
| 09/24/2008 | CN101272793A Sphingomyelin-containing medicine, food and drink or fodder |
| 09/24/2008 | CN101272787A Use of opioid receptor antagonists |
| 09/24/2008 | CN101272786A Lotion preparation containing pyridonecarboxylic acid derivative |
| 09/24/2008 | CN101272780A DPP IV inhibitor for use in the treatment of autoimmune diseases and graft rejection |
| 09/24/2008 | CN101272775A Cosmetic compositions comprising hydroxyfatty acids |
| 09/24/2008 | CN101270362A Novel serine protease genes related to DPPIV |